• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Harvard Bioscience, Inc. - Common Stock (NQ:HBIO)

    6.040 +0.030 (+0.50%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 9, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 16,554
    Open 6.090
    Bid (Size) 6.030 (200)
    Ask (Size) 6.210 (100)
    Prev. Close 6.010
    Today's Range 5.890 - 6.200
    52wk Range 3.755 - 9.400
    Shares Outstanding 42,688,246
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Sidoti Events, LLC's May Micro-Cap Virtual Conference
    Via ACCESS Newswire
    News headline image
    HBIO Q1 2026 Earnings Transcript ↗
    HBIO Q1 2026 Earnings Transcript 
    Via The Motley Fool

    Performance

    YTD
    -7.3%
    -7.3%
    1 Month
    -11.7%
    -11.7%
    3 Month
    +13.9%
    +13.9%
    6 Month
    -16.2%
    -16.2%
    1 Year
    +8.2%
    +8.2%

    More News

    Read More
    Harvard Bioscience Inc (NASDAQ:HBIO) Q1 Results Show Revenue Miss Offsets Earnings Beat ↗
    Via Chartmill
    News headline image
    Harvard Bioscience Announces First Quarter 2026 Financial Results
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Harvard Bioscience Inc. (NASDAQ:HBIO) Reports Mixed Q4 2025 Results and Cautious 2026 Outlook ↗
    Via Chartmill
    News headline image
    Earnings Scheduled For November 6, 2025 ↗
    Via Benzinga
    News headline image
    Harvard Bioscience to Participate in Upcoming Investor Conferences
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    News headline image
    Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    News headline image
    Harvard Bioscience (HBIO) Earnings Transcript ↗
    Via The Motley Fool
    Topics World Trade
    News headline image
    Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    Stay updated with the stocks that are on the move in today's after-hours session. ↗
    Via Chartmill
    News headline image
    Harvard Bioscience Announces Reverse Stock Split
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    News headline image
    Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    News headline image
    Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    News headline image
    Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    News headline image
    Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    News headline image
    Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    News headline image
    Harvard Bioscience Inc (NASDAQ:HBIO) Reports Mixed Q3 2025 Results Amid Restructuring Efforts ↗
    Via Chartmill
    News headline image
    Harvard Bioscience Announces Third Quarter 2025 Financial Results
    From Harvard Bioscience, Inc.
    Via GlobeNewswire
    News headline image
    These stocks have an unusual volume in today's session ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
    Via Benzinga
    News headline image
    These stocks are moving in today's session ↗
    Via Chartmill
    News headline image
    Specificity (OTCQB: SPTY) Signs LOI with Blackpearl – Global Push to End $250B Ad Tech Fraud – More Stocks Inside
    Via AB Newswire
    Topics Artificial Intelligence Fraud
    News headline image
    Check out the stocks that are attracting the most attention and driving market activity. ↗
    Via Chartmill
    News headline image
    Here are the top movers in Thursday's session. ↗
    Via Chartmill

    Frequently Asked Questions

    Is Harvard Bioscience, Inc. - Common Stock publicly traded?
    Yes, Harvard Bioscience, Inc. - Common Stock is publicly traded.
    What exchange does Harvard Bioscience, Inc. - Common Stock trade on?
    Harvard Bioscience, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Harvard Bioscience, Inc. - Common Stock?
    The ticker symbol for Harvard Bioscience, Inc. - Common Stock is HBIO on the Nasdaq Stock Market
    What is the current price of Harvard Bioscience, Inc. - Common Stock?
    The current price of Harvard Bioscience, Inc. - Common Stock is 6.040
    When was Harvard Bioscience, Inc. - Common Stock last traded?
    The last trade of Harvard Bioscience, Inc. - Common Stock was at 06/09/26 04:00 PM ET
    What is the market capitalization of Harvard Bioscience, Inc. - Common Stock?
    The market capitalization of Harvard Bioscience, Inc. - Common Stock is 257.84M
    How many shares of Harvard Bioscience, Inc. - Common Stock are outstanding?
    Harvard Bioscience, Inc. - Common Stock has 258M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.